Table 1 Demographic characteristics
From: COVID-19-associated mucormycosis: an update of anesthetic management
Variables | Patients number |
|---|---|
Age (years) | 60 (32–80) |
Sex (male/female) | 40/17 |
Weight (kg) | 67 (52–120) |
ASA* grade II/III/IV | 18/13/26 |
Mallampati I/II/III | 24/29/4 |
Post procedure elective tracheostomy | 1/57 |
Predisposing factors | Â |
Diabetes mellitus | 24 |
DM* + HTN* + IHD* | 15 |
DM + HTN | 17 |
HTN | 1 |
CABG* | 2 |
Angioplasty | 3 |
On steroids | 57 |
COVID-19-associated mucormycosis | 57 |
History of ICU* admission during COVID-19 infection | 19 |
History of requirement oxygen (ICU/ward) during COVID-19 infection | 28 |
Average day stay in ward/ICU during COVID-19 | 11 (6–25) |
Occurrence of mucormycosis average days after COVID-19 infection | 32 (6–150) |